Seroprevalence of hepatitis B surface antigen and hepatitis B e antigen among childbearing-age women in Mianyang, China

Seroprevalence of hepatitis B surface antigen and hepatitis B e antigen among childbearing-age women in Mianyang, China

Introduction: Few studies have focused on hepatitis B virus (HBV) infection among childbearing-age women. This study explored hepatitis B surface antigen (HBsAg) seroprevalence and hepatitis B e antigen (HBeAg) seroprevalence and their associated factors among childbearing-age women. Methodology: A...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min Wang, Hong Li, Yulin Ji, Yuanji Ma, Liping Wang, Tao Ren, Fengsu Hou, Ping Yuan
Format:	Article
Language:	English
Published:	The Journal of Infection in Developing Countries 2015-07-01
Series:	Journal of Infection in Developing Countries
Subjects:	childbearing-age women hepatitis B surface antigen hepatitis B e antigen seroprevalence China
Online Access:	https://jidc.org/index.php/journal/article/view/6938
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

The Prevalence of Occult Hepatitis B Virus Infection among Hepatitis B Surface Antigen Sero-negative Blood Donors
by: Babandina Muhammad Musa 1, Ocheme Julius Okojokwu 2, Musa Saleh Makeri 3, Khadijat Toyi Musa 4, Amos Dangana 5, Maryam Aladodo 6, Saheed Adekola 7, Nura Muhammad Bunza 8, Zainab Usman-kanfani9, Clara Obiegue 10, Abbas M Babandina11 Musa Abidemi Muhibi 12,
Published: (2025-05-01)

Knowledge and behaviors about hepatitis B prevention and control among carriers of hepatitis B surface antigen
by: LI Siwen, ZHOU Tiantian, ZHANG Chao, ZHANG Dan, HU Weijun
Published: (2025-03-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Decreasing hepatitis B seroprevalence in pregnant women in Taiwan between 2016 and 2021: a claim-based cohort study
by: Li-Nien Chien, et al.
Published: (2025-01-01)

Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya
by: Hamida El-Magrahe, et al.
Published: (2010-03-01)

Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA
by: Hongyu Shen, et al.
Published: (2019-11-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021
by: Olena Nesterova
Published: (2025-07-01)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
by: Shao-Juan Wang, et al.
Published: (2021-01-01)

Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma
by: Bingyan Hao, et al.
Published: (2025-03-01)

Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels
by: Deliang Huang, et al.
Published: (2023-12-01)

The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients
by: Lei Tan, et al.
Published: (2025-12-01)

Hepatitis B seroprevalence in children and women and the impact of the hepatitis B vaccination program in the Black Sea Region of Turkey
by: Guner Karatekin, et al.
Published: (2013-12-01)

Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria
by: Michael O Iroezindu, et al.
Published: (2013-12-01)

Mass screening of hepatitis B and C in Burkina Faso: seroprevalence update and impact of hepatitis B vaccine
by: Armel Moumouni Sanou, et al.
Published: (2024-09-01)

Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
by: Sukjin Hong, et al.
Published: (2025-04-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

Seroprevalence of antibodies to hepatitis A, B and C viruses across all age groups in Chonburi Province, Thailand, 2022–2023
by: Nasamon Wanlapakorn, et al.
Published: (2025-12-01)

Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women attending a tertiary care hospital in Mogadishu, Somalia, 2017–2021
by: Mohamed Abdulkadir Hassan-Kadle, et al.
Published: (2025-07-01)

Study on seroprevalence of hepatitis delta in a regional hospital in western Turkey
by: Sukran Kose, et al.
Published: (2012-11-01)

Dynamic predicting hepatitis B surface antigen decline rate during treatment for patients with chronic hepatitis B
by: Ying Xin, et al.
Published: (2025-09-01)

Serologic and molecular characteristics of hepatitis B virus infection in vaccinated schizophrenia patients in China
by: Yiying Wang, et al.
Published: (2016-04-01)

Pregnancy and Hepatitis B Virus Infection
by: Selma TOSUN
Published: (2016-12-01)

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
by: Takanori Suzuki, et al.
Published: (2025-01-01)

Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City
by: Razhan Sabah Hassan, et al.
Published: (2023-04-01)

Seroprevalence of Hepatitis B Virus Infection and Associated Factors among Cancer Patients at Hawassa University Comprehensive Specialized Hospital, Ethiopia
by: Surafel Nadew, et al.
Published: (2024-05-01)

Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy
by: Ruyu Liu, et al.
Published: (2023-12-01)

Evaluation of Vaccination Status, Awareness, and Seroprevalence of Hepatitis B Virus Infection among Female Sex Workers in Jos
by: Hashimu Zakari, et al.
Published: (2024-06-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Single Nucleotide Polymorphisms of Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) and Susceptibility to Chronic Viral Hepatitis B and C Infections
by: Moisés Enciso-Vargas, et al.
Published: (2018-03-01)

Seroprevalence to Hepatitis B Virus among Prisoners Taking into Account Age, HIV Status, and Injection Drug Use
by: M. V. Piterskiy, et al.
Published: (2024-03-01)

Prevalence of hepatitis B virus infection and associated factors among adults intrafamilial household contacts attending antenatal care clinics in the Central Ethiopian region: from pregnant women index cases
by: Yilma Markos Larebo, et al.
Published: (2025-02-01)

Seroprevalence of hepatitis B surface antigen and associated risk factors among pregnant women
by: Sirin Cetin, et al.
Published: (2018-10-01)

Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
by: I. A. Gabdrakhmanov, et al.
Published: (2016-02-01)

Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience
by: Bojović Ksenija, et al.
Published: (2020-01-01)

Prevalence and predictors of hepatitis B in Jeddah City, Saudi Arabia: a population-based seroprevalence study
by: Rajaa M Al-Raddadi, et al.
Published: (2016-10-01)

Immune response to hepatitis B vaccine among north Iranian healthcare workers and its related factors
by: Farahnaz Joukar, et al.
Published: (2017-06-01)

Seroprevalence of hepatitis A,B, and C viruses in Turkish alcoholic cirrhotics and the impact of hepatitis B on clinical profile
by: Fatih Tekin, et al.
Published: (2015-03-01)

Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D
by: Sandra Rodrigues Xavier, et al.
Published: (2025-07-01)